According to FutureWise analysis the market for Nanobodies in 2023 is US$ 0.36 billion, and is expected to reach US$ 2.05 billion by 2031 at a CAGR of 24.32%.
Nanobodies are modified antibodies with a single antigen-binding domain created by heavy chains. Due to their size and single-chain nature, these antibodies can be designed and are useful for a wide range of applications in research, pharmaceutical development, and medical diagnosis. Nanobodies, have a variety of special qualities, such as small size, good solubility, enhanced stability, rapid blood clearance, and deep tissue penetration. Nanobodies are therefore developing into a promising diagnostic and therapeutic tool. As imaging tracers, nanobodies enable early high-quality image acquisition, complete assessment of the situation, and then individualized precision therapy. By delivering lesion-specific medications and effector domains to the site of the lesion, nanobodies as therapeutic agents provide targeted therapy, enhancing the specificity and effectiveness of the treatment.
Single domain antibodies known as nanobodies are derived from heavy-chain antibodies in mammals and have special characteristics such as nanoscale size, robust structure, stable and soluble behaviour in aqueous solution, reversible protein folding, high affinity and specificity for only one cognate target, among others. Applications for nanobodies vary from fundamental research to medical therapeutics. Nanobodies, which are used as affinity capture reagents because of their tiny size and single domain chain, have a greater binding surface and less nonspecific background binding. Additionally, nanobodies can be used to treat cancer and other diseases by obstructing ligand-receptor interactions, such as blocking anti-TNF-a to treat arthritis or antagonizing anti-von Willebrand factor to avoid thrombosis. To track antigen activity, nanobodies can also be produced inside cells and combined with a fluorescent protein. The ability of nanobodies to anchor proteins is advantageous, which is crucial when a protein is crystallizing. Due to their capacity to bind proteins in a specific conformation and stabilize flexible domains, nanobodies are thus utilized in a variety of protein crystallization studies.
FutureWise Market Research has published a report that provides an insightful analysis of Nanobodies market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.
According to the analysis conducted by FutureWise research analysts, the Nanobodies market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.